SHELBY RIGGS: Open Payments
NPI 1649785296 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 31 payments from 14 companies in 2025. Trend: 2023 $802 · 2024 $1,061 · 2025 $621
Food & beverage: $609Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $153 |
| Lilly USA, LLC | 5 | $80 |
| Gilead Sciences, Inc. | 4 | $68 |
| Verona Pharma, Inc. | 2 | $46 |
| Abbott Laboratories | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
Products named: MOUNJARO, Rybelsus, Ohtuvayre, Ozempic, FREESTYLE LIBRE 3, Kerendia, SAPIEN 3 Ultra RESILIA, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
